Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exemestane plus GnRH analogue versus tamoxifen plus GnRH analogue in premenopausal endocrine-responsive breast cancer
2004-000168-28Phase 3Completed
- Sponsor
- International Breast Cancer Study Group
- Start
- Jul 2005
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in breast cancer comparing GnRH analogue plus exemestane with GnRH analogue plus tamoxifen (2 arms). Primary endpoint: Disease-free survival. Started Jul 2005; status: completed.
02
Drugs
exemestanetamoxifentriptorelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-000168-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000168-28.